S. Murphy

441 total citations
13 papers, 341 citations indexed

About

S. Murphy is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, S. Murphy has authored 13 papers receiving a total of 341 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 4 papers in Genetics and 3 papers in Oncology. Recurrent topics in S. Murphy's work include Chronic Lymphocytic Leukemia Research (4 papers), Neutropenia and Cancer Infections (2 papers) and Acute Lymphoblastic Leukemia research (2 papers). S. Murphy is often cited by papers focused on Chronic Lymphocytic Leukemia Research (4 papers), Neutropenia and Cancer Infections (2 papers) and Acute Lymphoblastic Leukemia research (2 papers). S. Murphy collaborates with scholars based in United States. S. Murphy's co-authors include Albert F. LoBuglio, Michael J. Keating, F.M. Huennekens, E. M. Hersh, DJ Stewart, Gerald H. Elkan, Deborah A. Thomas, E. Hersh, Stephen J. O’Brien and Steven M. Kornblau and has published in prestigious journals such as Blood, Journal of Bacteriology and Archives of Biochemistry and Biophysics.

In The Last Decade

S. Murphy

13 papers receiving 318 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
S. Murphy United States	8	129	121	85	80	74	13	341
Silvia Manfroi Italy	13	96 0.7×	302 2.5×	51 0.6×	167 2.1×	46 0.6×	34	491
Sayoko Doisaki Japan	12	98 0.8×	182 1.5×	19 0.2×	117 1.5×	90 1.2×	28	387
Gerald E. Bloom United States	10	69 0.5×	120 1.0×	12 0.1×	146 1.8×	28 0.4×	17	444
Etsuko Aoki United States	8	86 0.7×	136 1.1×	29 0.3×	174 2.2×	58 0.8×	16	364
Etsuko Shima Japan	7	70 0.5×	121 1.0×	55 0.6×	143 1.8×	146 2.0×	13	401
Amber C. King United States	11	108 0.8×	204 1.7×	34 0.4×	157 2.0×	26 0.4×	31	419
Tomoo Osumi Japan	11	35 0.3×	90 0.7×	83 1.0×	110 1.4×	40 0.5×	54	374
Hee‐Jo Baek South Korea	11	44 0.3×	41 0.3×	38 0.4×	116 1.4×	28 0.4×	36	283
G Fugazza Italy	8	60 0.5×	259 2.1×	12 0.1×	82 1.0×	64 0.9×	14	389
Frank Meloni United States	10	98 0.8×	139 1.1×	11 0.1×	50 0.6×	49 0.7×	17	370

Countries citing papers authored by S. Murphy

Since Specialization

Citations

This map shows the geographic impact of S. Murphy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Murphy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Murphy more than expected).

Fields of papers citing papers by S. Murphy

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. Murphy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Murphy. The network helps show where S. Murphy may publish in the future.

Co-authorship network of co-authors of S. Murphy

This figure shows the co-authorship network connecting the top 25 collaborators of S. Murphy. A scholar is included among the top collaborators of S. Murphy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. Murphy. S. Murphy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

1.

Thomas, Deborah A., et al.. (1997). The hyper-CVAD regimen improves outcome in relapsed acute lymphoblastic leukemia. Leukemia. 11(12). 2039–2044. 61 indexed citations

2.

Keating, Michael J., S. Murphy, Hagop M. Kantarjian, et al.. (1988). Multiple agent chemotherapy (POACH) in previously treated and untreated patients with chronic lymphocytic leukemia.. PubMed. 2(3). 157–64. 59 indexed citations

3.

Quesada, Jorge R., et al.. (1982). Evaluation of therapy with methanol extraction residue of BCG (MER). Cancer Immunology Immunotherapy. 14(1). 4–9. 6 indexed citations

4.

Richman, Stephen P., et al.. (1981). Augmentation of ADCC in mice by microbial fractions. Cancer Immunology Immunotherapy. 11(3). 3 indexed citations

5.

Hersh, E. M., et al.. (1980). Host defense deficiency in hairy cell leukemia and its correction by leukocyte transfusion. Blood. 56(3). 526–533. 15 indexed citations

6.

Hersh, E. M., S. Murphy, & Jordan U. Gutterman. (1979). Some host defense modifying effects of intravenous microbial adjuvants. Proceedings of the American Association for Cancer Research. 20. 1 indexed citations

7.

Stewart, DJ, et al.. (1979). The effectiveness of rubidazone in hairy cell leukemia (leukemic reticuloendotheliosis). Blood. 54(2). 298–304. 36 indexed citations

8.

Murphy, S., et al.. (1978). Response of L2C guinea pig leukemia to chemoimmunotherapy. Proceedings of the American Association for Cancer Research. 19. 1 indexed citations

9.

Murphy, S. & E. Hersh. (1978). Immunotherapy of leukemia and lymphoma.. PubMed. 15(2). 181–203. 15 indexed citations

10.

Murphy, S. & Albert F. LoBuglio. (1976). Drug therapy of autoimmune hemolytic anemia.. PubMed. 13(4). 323–34. 59 indexed citations

11.

Murphy, S., et al.. (1969). Enzymatic conversion of vitamin B12a to adenosyl-B12: Evidence for the existence of two separate reducing systems. Archives of Biochemistry and Biophysics. 134(1). 95–102. 65 indexed citations

12.

Rosselet, J. P., et al.. (1969). Endotoxin-free Biologically Active Component of Escherichia coli. Journal of Bacteriology. 98(2). 434–436. 3 indexed citations

13.

Murphy, S. & Gerald H. Elkan. (1965). NITROGEN METABOLISM OF SOME STRAINS OF RHIZOBIUM JAPONICUM HAVING DIFFERENT NODULATING CAPACITIES. Canadian Journal of Microbiology. 11(6). 1039–1041. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact